Get started
Author

Alexandra Roux

Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study
2020 · Michelle Rosenzwajg, Randa Salet, et al. · Diabetologia · 114
PDF
Deep phenotyping of immune cell populations by optimized and standardized flow cytometry analyses
2018 · Fabien Pitoiset, Lydie Cassard, et al. · Cytometry Part A · 84
A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing–remitting multiple sclerosis
2023 · C. Louapre, M. Rosenzwajg, et al. · Journal of Neurology · 33
Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types
2024 · Nicolas Tchitchek, Marie Binvignat, et al. · Annals of the Rheumatic Diseases · 23
PDF
Impact of keratin intermediate filaments on insulin‐mediated glucose metabolism regulation in the liver and disease association
2015 · Alexandra Roux, Stéphane Gilbert, et al. · The FASEB Journal · 21
Clinical correlates of lifetime and current comorbidity patterns in autoimmune and inflammatory diseases
2024 · Signe Hässler, Roberta Lorenzon, et al. · Journal of Autoimmunity · 17
Keratin 8/18 regulation of insulin receptor signaling and trafficking in hepatocytes through a concerted phosphoinositide‐dependent Akt and Rab5 modulation
2017 · Alexandra Roux, Anne Loranger, et al. · The FASEB Journal · 13
Immunologic Profiling Suggests an Association Between Treg Cell Dysfunction and Pain in Knee Osteoarthritis
2025 · Marie Binvignat, Johanna Dubois, et al. · Arthritis & Rheumatology · 8
PDF
Efficacy and safety of low-dose IL-2 in people with newly diagnosed type 1 diabetes (DIABIL-2): a double-blind, multicentre, randomised, placebo-controlled, phase 2b trial
2026 · Michelle Rosenzwajg, Agnès Hartemann, et al. · The Lancet Diabetes & Endocrinology · 1
A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease
2026 · Marie Binvignat, Federica Martina, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Signature immunologique de la gonarthrose : rôle des lymphocytes T régulateurs dans la douleur. Résultats de l’étude TRANSIMMUNOM
2024 · M. Binvignat, J. Dubois, et al. · Revue du Rhumatisme
Pos0792 Immunological Profiling of Pain in Knee Osteoarthritis: Treg Cells as Potential New Key Players in Symptomatic Knee Osteoarthritis
2024 · M. Binvignat, J. Dubois, et al. · Annals of the Rheumatic Diseases
Immunological Profiling of Pain in Knee Osteoarthritis: Treg Cells as Potential New Key Players in Symptomatic Knee Osteoarthritis.
2024 · Marie Binvignat, Johanna Dubois, et al. · Osteoarthritis and Cartilage
PDF
Characterization of the dynamics of immune cells during low-dose interleukin-2 treatment in healthy volunteers.
2022 · Dubois, Johanna, Pitoiset, Fabien, et al. · HAL
TCR repertoire as biomarker of immune diseases : applications to autoimmune diseases and COVID-19
2022 · Stys, Paul, Barennes, Pierre, et al. · HAL
Low-Dose Interleukin 2 in Children with Recently Diagnosed Type 1 Diabetes: A Phase 1/2 Randomised, Double-Blind, Placebo-Controlled Dose Finding Study
2019 · Randa Salet, Michelle Rosenzwajg, et al. · SSRN Electronic Journal
Les kératines 8/18 dans la régulation de la voie de signalisation et du trafic vésiculaire du récepteur de l'insuline chez les cellules hépatiques
2017 · Alexandra Roux · Corpus Université Laval (Université Laval)
Works count: 17
Citation count: 314
H-index: 8
I10-index: 7
Year
Topic
Type